With regard to molecular subtypes, BC can be broadly classified into three groups: hormone receptor-positive (HR+) (expressing estrogen receptor (ER+) or progesterone receptor (PR+)), human epidermal growth factor receptor 2-positive (HER2+), or triple-negative breast cancer (TNBC) [10,11]. Here, ESR1 is linked to triple-negative breast carcinoma.